Portal de investigación
Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-blind, Placebo-controlled Trial.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Calderón R
- Palao MJ
- Brandi P
- Conejero L
- Saz-Leal P
- Fernández-Pérez C
- Sancho D
- Subiza JL
- Casanovas M
Grupos
Abstract
Recurrent wheezing in children represents a severe public health concern. Wheezing attacks (WA), mainly associated with viral infections, lack effective preventive therapies.
Datos de la publicación
- ISSN/ISSNe:
- 1073-449X, 1535-4970
- Tipo:
- Article
- Páginas:
- 462-472
- PubMed:
- 33705665
- Factor de Impacto:
- 5,950 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE AMER THORACIC SOC
Citas Recibidas en Web of Science: 76
Documentos
- No hay documentos
Filiaciones
Keywords
- Clinical trial, mucosal vaccination, trained immunity, wheezing attacks
Campos de Estudio
Cita
NIETO A,MAZÓN A,NIETO M,Calderón R,CALAFORRA S,SELVA B,UIXERA S,Palao MJ,Brandi P,Conejero L,Saz P,Fernández C,Sancho D,Subiza JL,Casanovas M. Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-blind, Placebo-controlled Trial. Am. J. Respir. Crit. Care Med. 2021. 204. (4):p. 462-472. IF:30,528. (1).